JLT Pharma Inc. is committed in delivering quality healthcare to the Filipino community. Most of the products are available for CLIDP applications and brand ownership. Moreso, with the dynamically evolving healthcare trends, JLT Pharma Inc. is dedicated in diversifying and expanding its product list to be made available in the Filipino patient care.
Distributors may opt to send their product request/s if not available with the current product list; and JLT Pharma Inc, with the best of its capacity, will source out the product and grant PCPR in accordance with PFDA regulatory compliance and timeline.
Information about their dosage form, dosage strength, shelf life, and pack size. Click for full details
DICLOFENAC SODIUM
KETOROLAC TROMETAMOL
PARACETAMOL
REMIMAZOLAM
ROCURONIUM BROMIDE
SEVOFLURANE
TRAMADOL HYDROCHLORIDE
CEFACLOR
CEFOTAXIME
CEFTAZIDIME
CEFTRIAXONE
CLOTRIMAZOLE + BETHAMETASONE + GENTAMICIN
IMIPINEM + CILASTATIN
MEROPENEM
METRONIDAZOLE
MOXIFLOXACIN
VANCOMYCIN
ALENDRONATE
IBANDRONIC ACID
AMINOSIL
TELMISARTAN + HYDROCHRLOTHIAZIDE (HCTZ)
BISOPROLOL FUMARATE + HYDROCHLOROTHIAZIDE (HCTZ)
DOBUTAMINE HCl
FUROSEMIDE
NICARDIPINE
NOREPINEPHRINE
SODIUM BICARBONATE
CITICOLINE
LEVITERACETAM
MAGNESIUM SULFATE
PREGABALIN
RIVASTIGMINE
IOHEXOL
GADOBUTROL
MYCOPHENOLATE MOFETIL
TACROLIMUS
DOCETAXEL
ANASTRAZOLE
GEFITINIB
LINAGLIPTIN
ENTECAVIR
GLUTATHIONE
METHYLPREDNISOLONE
TALADAFIL + TAMSULOSIN
VITAMIN C